LUFFF (Herbal Dispatch) Return-on-Tangible-Equity: 0.00% (As of Mar. 2026)


What is Herbal Dispatch Return-on-Tangible-Equity?

Herbal Dispatch LUFFF -2.00% Return-on-Tangible-Equity is 0.00% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 896 Drug Manufacturers companies, Herbal Dispatch ranks worse than 111607.03% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Herbal Dispatch's annualized net income for the quarter that ended in Mar. 2026 was $-2.47 Mil. Herbal Dispatch's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $-1.21 Mil. Therefore, Herbal Dispatch's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.

The historical rank and industry rank for Herbal Dispatch's Return-on-Tangible-Equity or its related term are showing as below:

LUFFF's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.795
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Herbal Dispatch  (OTCPK:LUFFF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Herbal Dispatch Return-on-Tangible-Equity Related Terms


Herbal Dispatch Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Herbal Dispatch's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Herbal Dispatch Return-on-Tangible-Equity Chart

Herbal Dispatch Annual Data
Trend Dec15 Dec16 Dec17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.25 -114.94 -738.76 0.00 0.00

Herbal Dispatch Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LUFFF vs ZTS, UTHR: Return-on-Tangible-Equity Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Herbal Dispatch's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Herbal Dispatch Return-on-Tangible-Equity vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Herbal Dispatch's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Herbal Dispatch's Return-on-Tangible-Equity falls into.



Herbal Dispatch Return-on-Tangible-Equity Calculation

Herbal Dispatch's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-1.335/( (-1.278+-0.948 )/ 2 )
=-1.335/-1.113
=N/A %

Herbal Dispatch's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-2.468/( (-0.948+-1.466)/ 2 )
=-2.468/-1.207
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Herbal Dispatch (LUFFF) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Herbal Dispatch and its competitors. According to the industry distribution chart, Herbal Dispatch ranks #999999 out of 896 companies in the Drug Manufacturers industry.
Is Herbal Dispatch's Return-on-Tangible-Equity too high?
Herbal Dispatch's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Herbal Dispatch ranks #999999 out of 896 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Herbal Dispatch's Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Herbal Dispatch ranks #999999 out of 896 companies for Return-on-Tangible-Equity. This places Herbal Dispatch in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.80, based on 896 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Herbal Dispatch and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Herbal Dispatch's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Herbal Dispatch stock overvalued right now?
Based on GuruFocus' analysis, Herbal Dispatch (LUFFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 35.2% below its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Herbal Dispatch (LUFFF), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Herbal Dispatch Business Description

Other Exchanges HA9:GermanyHERB:Canada
Address 1055 West Georgia Street, Suite 1750, Royal Centre, Vancouver, BC, CAN, V6E 3P3
Herbal Dispatch Inc owns and operates cannabis e-commerce platforms in both Canada and the United States and is dedicated to providing top-quality cannabis to informed consumers at affordable pricing. The company's flagship cannabis marketplace, Herbal Dispatch, is a trusted source for exclusive access to small-batch craft cannabis flowers and a wide array of other product formats. It generates revenue in one reportable segment: cannabis and cannabis-related products. Geographically, the company generates the majority of its revenue from Canada.